There are convincing data to suggest a relation between the lupus anticoagulant (LA) and thrombosis, fetal loss, and thrombocytopenia.1 2 The term 'antiphospholipid syndrome' has been used to describe this particular group of patients,3 and the predictive value of high concentrations of anticardiolipin for these features has been demonstrated. 4 Anticardiolipin test by radioimmunoassay has been performed since 1983,5 and approximately 90% of plasmas with LA activity bind to cardiolipin in an enzyme linked immunosorbent assay (ELISA).
The LA and anticardiolipin antibodies need not bind to identical antigens, however. We describe Accepted for publication 25 Figure 2 shows the percentage inhibition of IgM anti-PE activity when serum was mixed with decreasing concentrations of PE and cardiolipin. PE caused more marked inhibition of IgM anti-PE activity than did cardiolipin.
AFFINITY PURIFIED IgM ANTI-PE ACTIVITY
Incubation of the patient's serum with PE liposomes, then precipitation of these liposomes by (Fig. 3) . This preparation did not bind plates coated with cardiolipin or any other negatively charged phospholipids. with LA activity and anticardiolipin antibodies cross react with negatively charged phospholipids.9 10 12 13 Antibodies that have been affinity purified using cardiolipin liposomes have been shown to 
